A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders-Reference-Cited by-同舟云学术

A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders

Published:2020-10-28 Issue:8 Volume:4 Page:1340-1342
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Al‐Samkari Hanny¹^ORCID,Naik Rakhi P.²,Zakai Neil A.³

Affiliation:

1. Division of Hematology Massachusetts General HospitalHarvard Medical School Boston MA USA

2. Division of Hematology Johns Hopkins University Baltimore MD USA

3. Department of Medicine Department of Pathology & Laboratory Medicine Larner College of Medicine at the University of Vermont Burlington VT USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12444

Reference9 articles.

1. Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective

2. Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia

3. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT‐Bleed study;Al‐Samkari H;Haematologica,2020

4. An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia;Al‐Samkari H;Haemophilia,2020

5. Systemic bevacizumab for high‐output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers;Al‐Samkari H;Orphanet J Rare Dis,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review;Journal of Clinical Medicine;2024-09-12

2. How I treat bleeding in hereditary hemorrhagic telangiectasia;Blood;2024-08-29

3. Rare bleeding disorders: Advances in management;Haemophilia;2024-03-18

4. Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia;Journal of Internal Medicine;2023-08-22

5. Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low‐hanging fruit meets inconvenient data;Journal of Thrombosis and Haemostasis;2022-05